Brind.

Brian moves from Teva Pharmaceuticals to Lupin Limited

1 report, 1 independent Updated Fri 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Brian joined Lupin Limited after leaving Teva Pharmaceuticals. At Teva, he held several senior leadership roles since 2015, most recently serving as Executive Vice President and Interim Global Chief Legal Officer. During his tenure, he led Teva’s global litigation strategy and served as General Counsel for the U.S. Generics business.

From equitybulls.com

Why it matters

Some supportBrind's analysis of the reports

Lupin CEO Vinita Gupta and Managing Director Nilesh Gupta stated that Brian’s deep legal expertise and understanding of the pharmaceutical industry will help strengthen Lupin’s governance framework and assist in navigating an evolving regulatory environment.

From equitybulls.com

Who's involved

  • BrianFormer Executive Vice President and Global Chief Legal Officer at Teva, now joining Lupin Limited.
  • Teva Pharmaceutical Industries Ltd.Former employer of Brian, where he held senior leadership roles including Global Chief Legal Officer.
  • Vinita GuptaCEO of Lupin Limited, who welcomed Brian to the executive leadership team.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped